Delivery Order SPE2DB20D3104-SPE2DB24FV9C8
Award Date
9/3/24
Potential Completion Date
9/4/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,488.56 firm fixed-price delivery order covers the supply of Ramelteon 8 mg tablets for the DLA Troop Support Medical program. The contract has a period of performance through November 27, 2024 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of 8 mg Ramelteon tablets, a medication used to treat insomnia. The contract has a ceiling value of $7,418.36 and is a firm fixed-price contract, with a period of performance ending on June 27, 2025. This contract is not set-aside and was competed openly. Amerisourcebergen Drug Corp is a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,543.17 firm fixed price delivery order is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order under contract SPE2DX15D1022 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RAMELTEON 8 MG TABLET UD 50S, a prescription sleep medication, with a ceiling value of $3,245.73 and a period of performance ending on September 5, 2024. The contract is a firm-fixed-price type and does not have a set-aside designation. AmerisourceBergen, through its...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,077.38, is for the supply of RAMELTEON 8 MG TABLET 30S, a medication used to treat insomnia. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,212.24 firm fixed-price delivery order is for the supply of Ramelteon 8 MG Tablet UD 50S, a medication used to treat insomnia. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,508.63 firm fixed-price delivery order is for the supply of RAMELTEON 8 MG TABLET 30S, a medication used to treat insomnia. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,961.10, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product RAMELTEON 8 MG TABLET UD 50S, with a performance period extending through June 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $89,490 to Amerisourcebergen Drug Corporation to supply 4561368131 Ramelteon 8 mg tablets. As the prime contractor, Amerisourcebergen will deliver 30 units of the specified pharmaceutical to a facility in Conshohocken, Pennsylvania, under a contract running from June 28 through June 29, 2023. The order is funded through the Defense Logistics Agency's pharmaceutical procurement programs and is not designated for...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifteen thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of thirty boxes of eight milligram ramelteon tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from September 6 to September 7, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of...